What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?

被引:13
作者
Bese, T [1 ]
Demirkiran, F [1 ]
Arvas, M [1 ]
Oz, AU [1 ]
Kosebay, D [1 ]
Erkun, E [1 ]
机构
[1] UNIV ISTANBUL,CERRAHPASA FAC MED,DEPT OBSTET & GYNECOL,ISTANBUL,TURKEY
关键词
epithelial ovarian cancer; second-look laparotomy; serum CA125;
D O I
10.1046/j.1525-1438.1997.00422.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the predictive value of serum CA125 level prior to second-look laparotomy in epithelial ovarian carcinoma, 45 patients who were clinically or radiologically tumor-free prior to a second-look laparotomy were studied. Serum CA125 levels were measured 10 days prior to the operation, and were compared with the surgico-pathological results. Twenty-eight (62%) patients were found to have tumor at surgery. The serum CA125 levels were greater than or equal to 35 Uml(-1) (42%) patients. Tumors were found in 14 (74%) of these 19 patients. Although a serum CA125 level greater than or equal to 35 Uml(-1) was a strong predictor of the presence of an intraperitoneal tumor, a level < 35 U ml(-1) was not predictive of a tumor-free state. When the cut-off level was accepted as 20 U ml(-1), 28 patients (62%) were found to have elevated CA125 level. The sensitivity, the specificity, the positive and negative predictive value and the false negative ratio were calculated as 79%, 65%, 79%, 65% and 21% respectively. The threshold value for a raised CA125 level was considered and a lower level of 20 Uml(-1) was suggested as a cut-off level prior to second-look laparotomy in evaluating patients with known epithelial ovarian cancer.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 25 条
[1]   REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[2]   CA-125 SERUM LEVELS CORRELATED WITH 2ND-LOOK OPERATIONS AMONG OVARIAN-CANCER PATIENTS [J].
BEREK, JS ;
KNAPP, RC ;
MALKASIAN, GD ;
LAVIN, PT ;
WHITNEY, C ;
NILOFF, JM ;
BAST, RC .
OBSTETRICS AND GYNECOLOGY, 1986, 67 (05) :685-689
[3]   CA125 MEASUREMENT IN EPITHELIAL OVARIAN-CANCER - A 10-YEAR ANNIVERSARY OF CLINICAL INVESTIGATION [J].
BERKOWITZ, RS .
GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :1-2
[4]   THE PROGNOSTIC IMPLICATIONS OF LOW SERUM CA-125 LEVELS PRIOR TO THE 2ND-LOOK OPERATION FOR STAGE-III AND STAGE-IV EPITHELIAL OVARIAN-CANCER [J].
GALLION, HH ;
HUNTER, JE ;
VANNAGELL, JR ;
AVERETTE, HE ;
CAIN, JM ;
COPELAND, LJ ;
HIGGINS, RV ;
HUSSEINZADEH, N ;
NAHHAS, WA ;
PARTRIDGE, EE ;
PURSELL, SH .
GYNECOLOGIC ONCOLOGY, 1992, 46 (01) :29-32
[5]   AN ASSESSMENT OF THE VALUE OF SERUM CA 125 MEASUREMENTS IN THE MANAGEMENT OF EPITHELIAL OVARIAN-CARCINOMA [J].
GARD, GB ;
HOUGHTON, CRS .
GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :283-289
[6]   THE PROGNOSTIC-SIGNIFICANCE OF THE HALF-LIFE OF SERUM CA-125 IN PATIENTS RESPONDING TO CHEMOTHERAPY FOR EPITHELIAL OVARIAN-CARCINOMA [J].
HAWKINS, RE ;
ROBERTS, K ;
WILTSHAW, E ;
MUNDY, J ;
FRYATT, IJ ;
MCCREADY, VR .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (12) :1395-1399
[7]  
LAVIN PT, 1987, OBSTET GYNECOL, V69, P223
[8]  
LUESLEY D, 1988, LANCET, V2, P599
[9]   CORRELATION OF ABDOMINAL ULTRASOUND AND COMPUTED-TOMOGRAPHY SCANS WITH 2ND-LOOK OR 3RD-LOOK LAPAROTOMY IN PATIENTS WITH OVARIAN-CARCINOMA [J].
LUND, B ;
JACOBSEN, K ;
RASCH, L ;
JENSEN, F ;
OLESEN, K ;
FELDTRASMUSSEN, K .
GYNECOLOGIC ONCOLOGY, 1990, 37 (02) :279-283
[10]   CA-125 MEASURED BEFORE 2ND-LOOK LAPAROTOMY IS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER [J].
MAKAR, AP ;
KRISTENSEN, GB ;
BORMER, OP ;
TROPE, CG .
GYNECOLOGIC ONCOLOGY, 1992, 45 (03) :323-328